SCHEMBL20209562

SCHEMBL20209562

Cc1ccc(OC2CCCC(Nc3ncc(Cl)c(-c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)n3)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 11/20 0.51
▸ CCNT1 O60563 10/20 0.51
▸ CDK9 P50750 10/20 0.51
▸ CCNH P51946 9/20 0.51
▸ CCNK O75909 5/20 0.51
▸ CDK12 Q9NYV4 5/20 0.51
▸ CDK13 Q14004 4/20 0.51
▸ MNAT1 P51948 7/20 0.50
▸ CDK2 P24941 5/20 0.47
▸ CCNA2 P20248 3/20 0.47
▸ RPS6KA3 P51812 1/20 0.47
▸ CCNE1 P24864 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ EGFR P00533 3/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ HTR6 P50406 3/20 0.40
▸ DRD2 P14416 2/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR7 P34969 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20190962 0.93 CDK7 (0.53) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL20209310 0.93 CDK7 (0.53) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL20209673 0.93 CDK7 (0.49) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL29746692 0.90 CDK7 (0.48) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL22654520 0.90 CDK7 (0.48) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL20191043 0.90 CDK7 (0.48) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL19605654 0.85 CDK7 (0.53) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL16665131 0.85 CDK7 (0.55) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL28346026 0.85 CDK7 (0.49) CDK7CCNT1CDK9CCNHCCNK
SCHEMBL28346025 0.85 CDK7 (0.49) CDK7CCNT1CDK9CCNHCCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098361-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 12 (CDK12) AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 — — WO disclosed
Send feedback